REQUEST A DEMO
Total
USD $0.00
Search more companies

Rapidiagnostics S.A. (Ecuador)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Rapidiagnostics S.A. Profile Updated: April 13, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Spanish Download a sample report

Rapidiagnostics S.A. is an enterprise in Ecuador, with the main office in Guayaquil. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. It was first established on May 03, 2010. It currently has a total number of 20 (2021) employees. From the latest financial highlights, Rapidiagnostics S.A. reported a net sales revenue drop of 43.01% in 2022. Its’ total assets recorded a growth of 239.12%. The net profit margin of Rapidiagnostics S.A. decreased by 0.29% in 2022.

Headquarters
Av Juan Tanca Marengo Mz 21, Solar 18 Bldg.
Guayaquil; Guayas;

Contact Details: Purchase the Rapidiagnostics S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Rapidiagnostics S.A. report to view the information.
Outstanding Shares:
Purchase the Rapidiagnostics S.A. report to view the information.
Registered Capital:
Purchase the Rapidiagnostics S.A. report to view the information.
Incorporation Date:
May 03, 2010
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
99%
Purchase this report to view the information.
1%
Company Performance
Financial values in the chart are available after Rapidiagnostics S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
-43.01%
Total operating revenue
-43%
Operating profit (EBIT)
-13.94%
EBITDA
21.49%
Net Profit (Loss) for the Period
-47.67%
Total assets
239.12%
Total equity
74.46%
Operating Profit Margin (ROS)
2.9%
Net Profit Margin
-0.29%
Return on Equity (ROE)
-11.36%
Debt to Equity Ratio
25.45%
Quick Ratio
-6.24%
Cash Ratio
-3.96%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?